Please login to the form below

Not currently logged in
Email:
Password:

Diabetes prevention

This page shows the latest Diabetes prevention news and features for those working in and with pharma, biotech and healthcare.

FDA rejects Provention Bio’s type 1 diabetes prevention drug

FDA rejects Provention Bio’s type 1 diabetes prevention drug

The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) denying approval for Provention Bio’s type 1 diabetes (T1D) prevention drug teplizumab.

Latest news

  • FDA panel backs Provention Bio’s type 1 prevention drug teplizumab FDA panel backs Provention Bio’s type 1 prevention drug teplizumab

    A US Food and Drug Administration (FDA) panel has voted in favour of Provention Bio’s type 1 diabetes prevention drug teplizumab, setting it up for a potential approval in July. ... Compared to placebo, children and adults who were considered high-risk

  • Best practice in UK diabetes celebrated at virtual QiC Diabetes Awards 2020 Best practice in UK diabetes celebrated at virtual QiC Diabetes Awards 2020

    by Cwm Taf Morgannwg University Health Board. 6. Diabetes Education Programmes – Healthcare Professionals. ... by The Paula Carr Diabetes Charitable Trust. 8. Prevention, Remission and Early Diagnosis.

  • World Diabetes Day 2019 World Diabetes Day 2019

    The findings coincide with World Diabetes Day, a global awareness campaign focused on diabetes mellitus. ... Diabetes is a chronic condition, and is a leading cause of blindness, lower-limb amputation, cardiovascular disease and kidney failure.

  • Provention Bio wins PRIME designation for type 1 diabetes prevention drug Provention Bio wins PRIME designation for type 1 diabetes prevention drug

    Back in June, Provention Bio saw its share price double after releasing data which showed that the experimental immunotherapy could delay the onset of type 1 diabetes in children and adults ... prevention of relapse," stated Ashleigh Palmer, CEO of

  • Tiziana joins type 1 diabetes prevention field Tiziana joins type 1 diabetes prevention field

    It is being evaluated in the treatment of a range of autoimmune diseases, including type 1 diabetes among others. ... Tiziana’s proprietary technology for the oral and nasal delivery of mAb’s in general, and foralumab specifically, have strong

More from news
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest Intelligence

  • The rising prevalence of diabetes in Europe The rising prevalence of diabetes in Europe

    Added to this is the unexplained increase of type 1 diabetes in children. ... The network wants to see action on several fronts:. Prevention. Keeping those with diabetes healthy.

  • The Chinese diabetes challenge The Chinese diabetes challenge

    Novo Nordisk has also placed great emphasis on physician training in diabetes, focusing on prevention, screening, optimising treatment and patient communication. ... Another leading player in China in the diabetes sector, Bayer, has also placed emphasis

  • Interview: Peter Meeus, Novo Nordisk Interview: Peter Meeus, Novo Nordisk

    Whatever they do to raise awareness of diabetes in terms of prevention, diagnosis and treatment we are also supporting.”. ... This can be a diabetes clinic or a programme to support diabetes footcare for example.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • New hires at bluebird bio, BioNTech and Provention Bio New hires at bluebird bio, BioNTech and Provention Bio

    In his role as CCO at Provention, Hoitt will be responsible for the development and execution of the company’s global commercial strategy for its type 1 diabetes prevention immunotherapy  ... one diabetes (T1D) patients and at-risk individuals and, in

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Improving Public Health Through Telemedicine

    Laurence Girard, CEO of Fruit Street Health, shares his tips for aspiring HealthTech entrepreneurs, his views on the future of telemedicine and digital health, and why he thinks healthcare companies should be funded by healthcare professionals

  • A new vision for tackling key illnesses

    Diabetes. The NHS plans to double the size of the NHS Diabetes Prevention Programme for type 2 diabetes. ... The Long-term Plan shows how technology will help to move diabetes services out of hospitals and support self-care.

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...